Pharmaceutical Executive
Record capital flows across global public and private markets has opened up new channels of investment in early-stage and novel science.
James Leech
Advertisement
Articles by James Leech
Advertisement
Latest Updated Articles
Cross-Border Funding in the Life SciencesAugust 21st 2018
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5